secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2022-02-23T23:59:59+00:00
Accession:  0001628280-22-003523
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q4 revenue $377.8M (+42.6%); FY 2021 revenue $1.526B (+63.2%)
----------------------------------------------------------------------

- Q4 diluted EPS $2.91 vs $2.36 YoY; net income $34.0M (+21.5%).
- Active earning OPTA VIA Coaches up 35.3% to 59,800; revenue per coach $6,321.
- FY 2022 guidance: revenue $1.72B-$1.79B; diluted EPS $14.50-$16.00.
- Cash and investments $109.5M; no interest-bearing debt; $16.8M dividend paid Feb 8.
- Repurchased $56M of stock in FY 2021; $10M in Q4 alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828022003523/0001628280-22-003523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828022003523/med-20220223.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-003523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer